Dr. Reddy’s Laboratories Ltd. ADR [RDY] stock prices are up 1.66% to $15.89 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The RDY shares have gain 8.39% over the last week, with a monthly amount glided 18.58%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] stock has seen the most recent analyst activity on June 05, 2025, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $16.90 for it. Previously, Nomura downgraded its rating to Neutral on December 19, 2024. On January 11, 2024, downgrade downgraded it’s rating to Underperform. HSBC Securities downgraded its rating to a Hold. Bernstein downgraded its rating to a Mkt Perform. BofA Securities upgraded its rating to Buy for this stock on March 17, 2023. In a note dated January 30, 2023, JP Morgan initiated an Underweight rating.
The stock price of Dr. Reddy’s Laboratories Ltd. ADR [RDY] has been fluctuating between $12.26 and $16.89 over the past year. Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] shares were valued at $15.89 at the most recent close of the market.
Analyzing the RDY fundamentals
The Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY] reported sales of 3.85B for trailing twelve months, representing a surge of 15.12%. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.18 and Total Capital is 0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY]’s Current Ratio is 1.92. On the other hand, the Quick Ratio is 1.37, and the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 3.43, the price to book ratio is 3.40 and price to earnings (TTM) ratio is 19.84.
Transactions by insiders
Recent insider trading involved Israeli Erez, Officer, that happened on Jul 29 ’24 when 65500.0 shares were purchased.
